1. Home
  2. NBIX vs VICR Comparison

NBIX vs VICR Comparison

Compare NBIX & VICR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

N/A

Current Price

$152.72

Market Cap

13.2B

Sector

Health Care

ML Signal

N/A

Logo Vicor Corporation

VICR

Vicor Corporation

N/A

Current Price

$234.74

Market Cap

15.1B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
NBIX
VICR
Founded
1992
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Industrial Machinery/Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
15.1B
IPO Year
1996
1995

Fundamental Metrics

Financial Performance
Metric
NBIX
VICR
Price
$152.72
$234.74
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
22
3
Target Price
$180.91
$217.50
AVG Volume (30 Days)
1.4M
874.6K
Earning Date
05-05-2026
04-21-2026
Dividend Yield
N/A
N/A
EPS Growth
41.95
1764.29
EPS
3.30
0.44
Revenue
$161,626,000.00
$452,701,000.00
Revenue This Year
$24.73
$37.01
Revenue Next Year
$13.14
$39.47
P/E Ratio
$45.72
$520.84
Revenue Growth
977.51
26.08
52 Week Low
$122.14
$45.44
52 Week High
$186.12
$382.65

Technical Indicators

Market Signals
Indicator
NBIX
VICR
Relative Strength Index (RSI) 34.68 49.88
Support Level $125.85 $134.89
Resistance Level $160.08 $232.35
Average True Range (ATR) 6.42 13.78
MACD -2.47 5.38
Stochastic Oscillator 9.54 91.91

Price Performance

Historical Comparison
NBIX
VICR

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

About VICR Vicor Corporation

Vicor Corp manufactures and markets modular power components and complete power systems for converting electrical power. It provides modular power converters and configurable products, power component products and integrated circuits, and related products. Its products include Converters, Power Systems, Filters, Custom Power Systems, Input Modules, and others. The principal markets for the Company's power converters and systems are large original equipment manufacturers (OEMs), original design manufacturers (ODMs) and their contract manufacturers, and smaller, lower volume users, which are broadly distributed across several market areas.

Share on Social Networks: